Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2

Sheng-Xiao Zhang¹, Jia Wang¹, He-Hua Sun¹, Jia-Qian Zhang¹, Guang-Ying Liu¹, Jing Luo¹, Pei-Feng He², Xiao-Feng Li³

Affiliations

¹ Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
² Department of Medical Information Management, Shanxi Medical University, Taiyuan, China.
³ Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China lxf_9859@sxmu.edu.cn.

PMID: 31611221
DOI: 10.1136/annrheumdis-2019-216246

Free article

Comment

Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2

Sheng-Xiao Zhang et al. Ann Rheum Dis. 2021 Aug.

Free article

. 2021 Aug;80(8):e130.

doi: 10.1136/annrheumdis-2019-216246. Epub 2019 Oct 14.

Authors

Sheng-Xiao Zhang¹, Jia Wang¹, He-Hua Sun¹, Jia-Qian Zhang¹, Guang-Ying Liu¹, Jing Luo¹, Pei-Feng He², Xiao-Feng Li³

Affiliations

¹ Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
² Department of Medical Information Management, Shanxi Medical University, Taiyuan, China.
³ Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China lxf_9859@sxmu.edu.cn.

PMID: 31611221
DOI: 10.1136/annrheumdis-2019-216246

No abstract available

Keywords: dermatomyositis; polymyositis; treatment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment in

Response to: 'Circulating regulatory T cells were absolutelydecreased in dermatomyositis/polymyositispatients and restored by low-dose IL-2' by Zhang et al.
Klatzmann D. Klatzmann D. Ann Rheum Dis. 2021 Aug;80(8):e131. doi: 10.1136/annrheumdis-2019-216267. Epub 2019 Oct 14. Ann Rheum Dis. 2021. PMID: 31611217 No abstract available.

Comment on

Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.
Rosenzwajg M, Lorenzon R, Cacoub P, Pham HP, Pitoiset F, El Soufi K, RIbet C, Bernard C, Aractingi S, Banneville B, Beaugerie L, Berenbaum F, Champey J, Chazouilleres O, Corpechot C, Fautrel B, Mekinian A, Regnier E, Saadoun D, Salem JE, Sellam J, Seksik P, Daguenel-Nguyen A, Doppler V, Mariau J, Vicaut E, Klatzmann D. Rosenzwajg M, et al. Ann Rheum Dis. 2019 Feb;78(2):209-217. doi: 10.1136/annrheumdis-2018-214229. Epub 2018 Nov 24. Ann Rheum Dis. 2019. PMID: 30472651 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2

Affiliations

Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources